Differential effects of taurine treatment and taurine deficiency on the outcome of renal ischemia reperfusion injury

作者: Mahmood S Mozaffari , Rafik Abdelsayed , Champa Patel , Hereward Wimborne , Jun Liu

DOI: 10.1186/1423-0127-17-S1-S32

关键词:

摘要: Taurine possesses membrane stabilization, osmoregulatory and antioxidant properties, aspects of relevance to ischemic injury. We tested the hypothesis that body taurine status is a determinant renal Accordingly, function structure were examined in control (C), taurine-treated (TT) deficient (TD) rats subjected bilateral ischemia (60 min) followed by reperfusion (IR); sham operated served as controls. Baseline urine osmolality was greater TD group than TT groups, an effect associated with increased aquaporin 2 level. The IR insult reduced (i.e., day-1 post insult); TD/IR displayed more marked recovery day-6 other two groups. Fluid sodium excretions lower group, suggesting propensity retention. Histopathological examination revealed presence tubular necrotic foci C/IR While architecture showed features resembling controls, TT/IR dilated tubules, which lacked immunostaining for 2, but not 1, suggestive proximal tubule origin. Finally, assessment cell proliferation apoptosis higher apoptotic Collectively, results indicate major

参考文章(43)
Stephen Schaffer, Junichi Azuma, Kyoko Takahashi, Mahmood Mozaffari, Why Is Taurine Cytoprotective? Advances in Experimental Medicine and Biology. ,vol. 526, pp. 307- 321 ,(2003) , 10.1007/978-1-4615-0077-3_39
Howard Trachtman, John A. Sturman, Taurine and Experimental Kidney Disease Advances in Experimental Medicine and Biology. ,vol. 359, pp. 149- 157 ,(1994) , 10.1007/978-1-4899-1471-2_16
H. Trachtman, R. Del Pizzo, S. Futterweit, D. Levine, P. S. Rao, E. Valderrama, J. A. Sturman, Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy. American Journal of Physiology-renal Physiology. ,vol. 262, ,(1992) , 10.1152/AJPRENAL.1992.262.1.F117
Melissa J. Burne-Taney, Manchang Liu, William M. Baldwin, Lorraine Racusen, Hamid Rabb, Decreased Capacity of Immune Cells to Cause Tissue Injury Mediates Kidney Ischemic Preconditioning Journal of Immunology. ,vol. 176, pp. 7015- 7020 ,(2006) , 10.4049/JIMMUNOL.176.11.7015
F. Lang, J. Madlung, D. Siemen, C. Ellory, A. Lepple-Wienhues, E. Gulbins, The involvement of caspases in the CD95(Fas/Apo-1)- but not swelling-induced cellular taurine release from Jurkat T-lymphocytes. Pflügers Archiv: European Journal of Physiology. ,vol. 440, pp. 93- 99 ,(2000) , 10.1007/S004240000247
Hong Gong, Weidong Wang, Tae-Hwan Kwon, Thomas Jonassen, Chunling Li, Troels Ring, Jørgen Frøkiær, Søren Nielsen, EPO and α-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney Kidney International. ,vol. 66, pp. 683- 695 ,(2004) , 10.1111/J.1523-1755.2004.00791.X
X. Han, A. B. Patters, D. P. Jones, I. Zelikovic, R. W. Chesney, The taurine transporter: mechanisms of regulation. Acta Physiologica. ,vol. 187, pp. 61- 73 ,(2006) , 10.1111/J.1748-1716.2006.01573.X
Mahmood S Mozaffari, Noriyuki Miyata, Stephen W Schaffer, Effects of taurine and enalapril on kidney function of the hypertensive glucose-intolerant rat American Journal of Hypertension. ,vol. 16, pp. 673- 680 ,(2003) , 10.1016/S0895-7061(03)00915-4
Craig Ricci, Viktoriya Solodushko, Mahmood Mozaffari, Stephen W. Schaffer, Viktor Pastukh, Contribution of the PI 3-kinase/Akt survival pathway toward osmotic preconditioning. Molecular and Cellular Biochemistry. ,vol. 269, pp. 59- 67 ,(2005) , 10.1007/S11010-005-2536-Z
Kimberly R. Spurgeon-Pechman, Deborah L. Donohoe, David L. Mattson, Hayley Lund, Leilani James, David P. Basile, Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium American Journal of Physiology-renal Physiology. ,vol. 293, ,(2007) , 10.1152/AJPRENAL.00279.2006